Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-10 4:16 pm Purchase | 2023-06-28 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Venrock Healthcare Capital Partners III, L.P. | 319,200 9.990% | 319,200 (New Position) | Filing |